388 related articles for article (PubMed ID: 35936698)
1. A Novel Nomogram Model to Predict the Recurrence-Free Survival and Overall Survival of Hepatocellular Carcinoma.
Zhang SW; Zhang NN; Zhu WW; Liu T; Lv JY; Jiang WT; Zhang YM; Song TQ; Zhang L; Xie Y; Zhou YH; Lu W
Front Oncol; 2022; 12():946531. PubMed ID: 35936698
[TBL] [Abstract][Full Text] [Related]
2. Development of nomogram models of inflammatory markers based on clinical database to predict prognosis for hepatocellular carcinoma after surgical resection.
Mao S; Yu X; Sun J; Yang Y; Shan Y; Sun J; Mugaanyi J; Fan R; Wu S; Lu C
BMC Cancer; 2022 Mar; 22(1):249. PubMed ID: 35255845
[TBL] [Abstract][Full Text] [Related]
3. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
[TBL] [Abstract][Full Text] [Related]
4. Development and evaluation of nomograms and risk stratification systems to predict the overall survival and cancer-specific survival of patients with hepatocellular carcinoma.
Kang X; Liu X; Li Y; Yuan W; Xu Y; Yan H
Clin Exp Med; 2024 Feb; 24(1):44. PubMed ID: 38413421
[TBL] [Abstract][Full Text] [Related]
5. Simplified nomograms based on platelet-associated models for survival prediction in Asian hepatocellular carcinoma patients after surgery.
Gu J; Zhang X; Wang Z; Cui R; Zhang J; Jia Y; Miao R; Fan H; Wang H; Li Y; Zhang J; Liu C; Qu K
Surg Oncol; 2019 Sep; 30():131-138. PubMed ID: 31500777
[TBL] [Abstract][Full Text] [Related]
6. Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with Hepatitis B Virus-Related Solitary Hepatocellular Carcinoma ≤10 cm and Without Portal Venous Tumor Thrombus.
Wang XH; Liao B; Hu WJ; Tu CX; Xiang CL; Hao SH; Mao XH; Qiu XM; Yang XJ; Yue X; Kuang M; Peng BG; Li SQ
Oncologist; 2020 Oct; 25(10):e1552-e1561. PubMed ID: 32663354
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Model Including Distinct Vascular Patterns to Estimate Survival in Hepatocellular Carcinoma.
Lin WP; Xing KL; Fu JC; Ling YH; Li SH; Yu WS; Zhang YF; Zhong C; Wang JH; Chen ZY; Lu LH; Wei W; Guo RP
JAMA Netw Open; 2021 Sep; 4(9):e2125055. PubMed ID: 34515782
[TBL] [Abstract][Full Text] [Related]
8. Nomograms Incorporating the CNLC Staging System Predict the Outcome of Hepatocellular Carcinoma After Curative Resection.
Liao R; Wei XF; Che P; Yin KL; Liu L
Front Oncol; 2021; 11():755920. PubMed ID: 35127471
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of systemic immune-inflammation index-based nomogram for early stage hepatocellular carcinoma after radiofrequency ablation.
Xin Y; Yang Y; Liu N; Chen Y; Wang Y; Zhang X; Li X; Zhou X
J Gastrointest Oncol; 2021 Apr; 12(2):735-750. PubMed ID: 34012662
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of sarcopenia combined with preoperative fibrinogen-albumin ratio in patients with intrahepatic cholangiocarcinoma after surgery: A multicenter, prospective study.
Yu H; Wang M; Wang Y; Yang J; Deng L; Bao W; He B; Lin Z; Chen Z; Chen K; Zhang B; Liu F; Yu Z; Ye L; Jin B; Chen G
Cancer Med; 2021 Jul; 10(14):4768-4780. PubMed ID: 34105304
[TBL] [Abstract][Full Text] [Related]
11. OHCCPredictor: an online risk stratification model for predicting survival duration of older patients with hepatocellular carcinoma.
Tan J; Yu Y; Lin X; He Y; Jin W; Qian H; Li Y; Xu X; Zhao Y; Ning J; Zhang Z; Chen J; Wu X
Hepatol Int; 2024 Apr; 18(2):550-567. PubMed ID: 37067674
[TBL] [Abstract][Full Text] [Related]
12. Nomogram for predicting post-therapy recurrence in BCLC A/B hepatocellular carcinoma with Child-Pugh B cirrhosis.
Qiao W; Sheng S; Xiong Y; Han M; Jin R; Hu C
Front Immunol; 2024; 15():1369988. PubMed ID: 38799452
[TBL] [Abstract][Full Text] [Related]
13. Nomograms for Predicting Hepatocellular Carcinoma Recurrence and Overall Postoperative Patient Survival.
Ma L; Deng K; Zhang C; Li H; Luo Y; Yang Y; Li C; Li X; Geng Z; Xie C
Front Oncol; 2022; 12():843589. PubMed ID: 35296018
[TBL] [Abstract][Full Text] [Related]
14. Development of preoperative prognostic models including radiological features for survival of singular nodular HCC patients.
Ding DY; Liu L; Li HL; Gan XJ; Ding WB; Gu FM; Sun DP; Li W; Pan ZY; Yuan SX; Zhou WP
Hepatobiliary Pancreat Dis Int; 2023 Feb; 22(1):72-80. PubMed ID: 35428596
[TBL] [Abstract][Full Text] [Related]
15. Predictive potential of Nomogram based on GMWG for patients with hepatocellular carcinoma after radical resection.
Ren L; Chen D; Xu W; Xu T; Wei R; Suo L; Huang Y; Chen H; Liao W
BMC Cancer; 2021 Jul; 21(1):817. PubMed ID: 34266388
[TBL] [Abstract][Full Text] [Related]
16. A web-based nomogram model for predicting the overall survival of hepatocellular carcinoma patients with external beam radiation therapy: A population study based on SEER database and a Chinese cohort.
Zhan G; Peng H; Zhou L; Jin L; Xie X; He Y; Wang X; Du Z; Cao P
Front Endocrinol (Lausanne); 2023; 14():1070396. PubMed ID: 36798659
[TBL] [Abstract][Full Text] [Related]
17. Nomograms to predict the long-time prognosis in patients with alpha-fetoprotein negative hepatocellular carcinoma following radical resection.
Huang J; Liu FC; Li L; Zhou WP; Jiang BG; Pan ZY
Cancer Med; 2020 Apr; 9(8):2791-2802. PubMed ID: 32096346
[TBL] [Abstract][Full Text] [Related]
18. Nomograms to predict survival outcomes after microwave ablation in elderly patients (>65 years old) with early-stage hepatocellular carcinoma.
Huang Z; Gu Y; Zhang T; Wu S; Wang X; An C; Huang J
Int J Hyperthermia; 2020; 37(1):808-818. PubMed ID: 32619374
[No Abstract] [Full Text] [Related]
19. The Prognostic Value of the Albumin to Gamma-Glutamyltransferase Ratio in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation.
Liu W; Zhang F; Quan B; Li M; Lu S; Li J; Chen R; Yin X
Dis Markers; 2021; 2021():3514827. PubMed ID: 34840628
[TBL] [Abstract][Full Text] [Related]
20. Predicting cancer-specific mortality in T1/2 hepatocellular carcinoma after radiofrequency ablation by competing risk nomogram: A population-based analysis.
He Q; Xiong Y; Xia P; Yang X; Yu Y; Chen Z
Clin Res Hepatol Gastroenterol; 2024 Feb; 48(2):102283. PubMed ID: 38219821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
